Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.
PLoS Negl Trop Dis. 2014 Apr 3;8(4):e2752. doi: 10.1371/journal.pntd.0002752. eCollection 2014 Apr.
The single-dose benzimidazoles used against Trichuris trichiura infections in humans are not satisfactory. Likewise, the benzimidazole, fenbendazole, has varied efficacy against Trichuris suis whereas Oesophagostomum dentatum is highly sensitive to the drug. The reasons for low treatment efficacy of Trichuris spp. infections are not known.
We studied the effect of fenbendazole, albendazole and levamisole on the motility of T. suis and O. dentatum and measured concentrations of the parent drug compounds and metabolites of the benzimidazoles within worms in vitro. The motility and concentrations of drug compounds within worms were compared between species and the maximum specific binding capacity (Bmax) of T. suis and O. dentatum towards the benzimidazoles was estimated. Comparisons of drug uptake in living and killed worms were made for both species.
The motility of T. suis was generally less decreased than the motility of O. dentatum when incubated in benzimidazoles, but was more decreased when incubated in levamisole. The Bmax were significantly lower for T. suis (106.6, and 612.7 pmol/mg dry worm tissue) than O. dentatum (395.2, 958.1 pmol/mg dry worm tissue) when incubated for 72 hours in fenbendazole and albendazole respectively. The total drug concentrations (pmol/mg dry worm tissue) were significantly lower within T. suis than O. dentatum whether killed or alive when incubated in all tested drugs (except in living worms exposed to fenbendazole). Relatively high proportions of the anthelmintic inactive metabolite fenbendazole sulphone was measured within T. suis (6-17.2%) as compared to O. dentatum (0.8-0.9%).
CONCLUSION/SIGNIFICANCE: The general lower sensitivity of T. suis towards BZs in vitro seems to be related to a lower drug uptake. Furthermore, the relatively high occurrence of fenbendazole sulphone suggests a higher detoxifying capacity of T. suis as compared to O. dentatum.
目前用于治疗人体旋毛虫感染的单剂量苯并咪唑类药物效果并不令人满意。同样,苯并咪唑类药物芬苯达唑对猪旋毛虫的疗效也各不相同,而对食道口线虫则高度敏感。导致旋毛虫属感染治疗效果不佳的原因尚不清楚。
我们研究了芬苯达唑、阿苯达唑和左旋咪唑对猪旋毛虫和食道口线虫运动的影响,并测量了体外蠕虫中母体药物化合物和苯并咪唑类药物代谢物的浓度。比较了不同物种之间蠕虫的运动和药物化合物浓度,并估计了猪旋毛虫和食道口线虫对苯并咪唑类药物的最大特异性结合能力(Bmax)。比较了两种物种活虫和死虫对药物的摄取情况。
当在苯并咪唑类药物中孵育时,猪旋毛虫的运动通常比食道口线虫的运动减少得少,但当在左旋咪唑中孵育时,猪旋毛虫的运动减少得更多。当分别在芬苯达唑和阿苯达唑中孵育 72 小时时,猪旋毛虫的 Bmax 明显低于食道口线虫(106.6 和 612.7 pmol/mg 干虫组织)(395.2 和 958.1 pmol/mg 干虫组织)。在所有测试的药物中,无论是死虫还是活虫,猪旋毛虫体内的总药物浓度(pmol/mg 干虫组织)均明显低于食道口线虫(除了暴露于芬苯达唑的活虫)。与食道口线虫相比(0.8-0.9%),猪旋毛虫体内相对较高比例的驱虫药无活性代谢物芬苯达唑砜(6-17.2%)。
结论/意义:猪旋毛虫在体外对 BZs 的一般较低敏感性似乎与其较低的药物摄取有关。此外,与食道口线虫相比,芬苯达唑砜的相对高发生率表明猪旋毛虫具有更高的解毒能力。